Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning

NCT00935246 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

202

Enrollment

OTHER

Sponsor class

Conditions

Depression
Continuous Antidepressant Abuse
Adverse Reaction to Drug

Interventions

DRUG: Escitalopram

Sponsor

Samsung Medical Center

Collaborators

[object Object]